Paragon 28 Inc at Morgan Stanley Global Healthcare Conference Transcript
Thank you, everyone, for joining us this afternoon. I'm Drew Ranieri, one of the medical device analyst here at Morgan Stanley. It's my pleasure to have Paragon 28 with us this afternoon. From the company, we have CEO, Albert DaCosta, CFO Steve Deitsch. And thank you both for being here today, making the trip over from Denver. Before we get started, quick disclosure. But for disclosures, please see the Morgan Stanley research disclosure website at morganstanley.com/researchdisclosures. With that, let's kind of get into the discussion today.
Questions & Answers
Maybe first for Albert, we can kind of dig into your views on the market. But to start, let's talk about the F&A market at large. You've sized it before about $6 billion, maybe growing high single digits. There's more commentary from large joint companies. I know you're a little apples and oranges there, but that there could be a modest
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
Trustpilot
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
